Momentum: MACD histogram positive and expanding (0.0623) suggests a potential short-term bounce is developing, but not enough to overturn the bearish MA structure yet.
RSI(6) ~39.7: weak/soft momentum (not deeply oversold), consistent with a drifting-down tape.
Levels: Resistance R1 ~67.85 then R2 ~69.17; Support S1 ~63.59 then S2 ~62.27. A break below ~63.6 would likely accelerate selling pressure.
Pattern-based forward odds provided: 50% chance of -1.17% next day, -3.51% next week, -3.42% next month — bearish bias near term.
Options Data
Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning/sentiment: OI put/call 1.18 implies heavier put open interest (more hedging / cautious-to-bearish stance).
Flow today: volume put/call 0.94 is slightly call-leaning intraday, but not a strong bullish signal.
Volatility: 30D IV ~50.2 vs historical vol ~40.8; IV percentile 87.2 = options are expensive and pricing elevated uncertainty.
Activity: today’s option volume ~4,045 (below 30D average; ~69.5% of avg) — no clear “panic” or aggressive bullish chase visible.
Takeaway: options market is cautious (hedged) rather than confidently bullish.
Technical Summary
Sell
9
Buy
6
Positive Catalysts
Hedge funds are buying (reported +766.97% QoQ buying amount), which can provide a medium-term support bid.
Neutral/Negative Catalysts
and removal from JPM February favorites list — reinforces “range-bound / tough Q4” narrative.
suggests investors are still protecting against downside.
Profitability worsened sharply: Net income $140M, -48.72% YoY; EPS $0.66, -47.62% YoY.
Gross margin: 23.24%, down ~0.98 YoY — indicates either higher costs, mix shift, or heavier promotions.
Bottom line: growth exists, but it’s low-quality (revenue up while earnings/margins down), which typically caps upside until margins stabilize.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend is negative/defensive: multiple price-target cuts and predominantly Hold/Neutral/Equal Weight stances.
Key change: 2026-02-02 JPMorgan downgraded to Neutral from Overweight; PT cut to $76 from $99, citing expected tough Q4, PC headwinds, and limited upside catalysts (range-bound view).
Other recent actions: Truist cut PT to $73 (Hold), Barclays cut PT to $77 (Equal Weight), Evercore cut PT to $80 (In Line). Earlier Morgan Stanley raised PT to $82 but kept Equal Weight.
Wall Street pros: expects some cyclical demand improvement and replacement cycles to help near-term.
Wall Street cons: doubts on sustainable comp/margin recovery; concern that benefits from product cycles won’t be enough to re-rate the stock materially in the near term.
Wall Street analysts forecast BBY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BBY is 83.33 USD with a low forecast of 60 USD and a high forecast of 99 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Analyst Rating
Wall Street analysts forecast BBY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BBY is 83.33 USD with a low forecast of 60 USD and a high forecast of 99 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
6 Hold
1 Sell
Moderate Buy
Current: 68.180
Low
60
Averages
83.33
High
99
Current: 68.180
Low
60
Averages
83.33
High
99
Evercore ISI
In Line -> Hold
downgrade
$80 -> $70
AI Analysis
2026-02-03
New
Reason
Evercore ISI
Price Target
$80 -> $70
AI Analysis
2026-02-03
New
downgrade
In Line -> Hold
Reason
Evercore ISI lowered the firm's price target on Best Buy to $70 from $80 and keeps an In Line rating on the shares. The firm adjusted targets among its Retail Broadlines & Hardlines coverage.
JPMorgan
Christopher Horvers
Overweight -> Neutral
downgrade
$99 -> $76
2026-02-02
Reason
JPMorgan
Christopher Horvers
Price Target
$99 -> $76
2026-02-02
downgrade
Overweight -> Neutral
Reason
JPMorgan analyst Christopher Horvers downgraded Best Buy to Neutral from Overweight with a price target of $76, down from $99. The firm sees a "tough" Q4 report for the company. JPMorgan has concerns that the "unique benefits" Best Buy say from Switch 2 in Q2 and the Windows 10 expiration in October will keep the stock range bound. In addition, higher memory market price will likely diminish the company's computing sales, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BBY